探索黄素在调节神经退行性疾病中的记忆障碍中的分子机制
Yousef Baghcheghi1,2, Fateme Razazpour2, Faezeh Mirzaee2
1Bio Environmental Health Hazards Research Center, Jiroft University of Medical Sciences, Jiroft, Iran.
Molecular biology reports
|December 9, 2024
概括
库尔库通过减少炎症和氧化应激减轻神经退行性疾病中的记忆丧失,有望保护记忆. 需要进一步的人体研究来确认其有效性并优化其使用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 记忆障碍是神经退行性疾病 (如阿尔茨海默氏症和帕金森病) 中的一个重要问题.
- 从Curcuma longa中获得的黄素因其对抗认知衰退的神经保护性质而受到研究.
研究的目的:
- 探索黄素神经保护作用的分子机制.
- 评估黄素在神经退行性疾病中改善认知缺陷的潜力.
主要方法:
- 临床前研究和新兴临床试验的审查.
- 分析黄素对神经元信号传递和突触可塑性通路 (例如NF-κB,PI3K/Akt) 的影响.
- 评估黄素对神经炎症,氧化应激和海马体树突脊柱密度的影响.
主要成果:
- 黄素增强神经元信号传递和突触可塑性.
- 它减少神经炎症和氧化应激,支持突触完整性.
- 动物模型显示,随着黄素治疗,海马体树突脊柱密度增加,空间学习得到改善.
结论:
- 库尔库在神经退行性疾病中的记忆障碍方面显示出潜在的治疗益处.
- 人类疗效数据,生物可用性和最佳剂量存在差距.
- 未来的研究应该集中在提高生物可用性和强大的人体试验上,以验证黄素的临床应用.
相关概念视频
Role of Neurotransmitters in Memory
431
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
431
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
96
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
96
Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
Alzheimer's Disease: Treatment
163
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
163
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Role of Cerebellum and Prefrontal Cortex in Memory
369
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
369


